![Robert Goeltz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Goeltz
Directeur Financier/CFO chez
ARCUS BIOSCIENCES, INC.
Fortune : 3 M $ au 30/06/2026
Profil
Robert C.
Goeltz is currently Chief Financial Officer at Arcus Biosciences, Inc. since 2023.
Formerly, Mr. Goeltz was Finance Director at Tularik, Inc. from 2002 to 2004, Chief Financial Officer at Onyx Pharmaceuticals, Inc. from 2013 to 2015, Chief Financial Officer & Senior Vice President at CytomX Therapeutics, Inc. from 2015 to 2017, and Chief Financial Officer at Unity Biotechnology, Inc. from 2017 to 2020.
Education includes undergraduate studies at Goizueta Business School-Emory and an MBA from UCLA Anderson School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ARCUS BIOSCIENCES, INC. 0,07 % | 11/05/2026 | 84 161 ( 0,07 % ) | 3 M $ | 30/06/2026 |
Postes actifs de Robert Goeltz
| Sociétés | Poste | Début |
|---|---|---|
| ARCUS BIOSCIENCES, INC. | Directeur Financier/CFO | 01/08/2020 |
Anciens postes connus de Robert Goeltz
| Sociétés | Poste | Fin |
|---|---|---|
| UNITY BIOTECHNOLOGY, INC. | Directeur Financier/CFO | 01/08/2020 |
| CYTOMX THERAPEUTICS, INC. | Directeur Financier/CFO | 15/05/2017 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Directeur Financier/CFO | 01/05/2015 |
Tularik, Inc.
 Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in cancer and inflammatory disease treatments | Directeur Financier/CFO | 01/08/2004 |
Formation de Robert Goeltz
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
46
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Tularik, Inc.
Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in cancer and inflammatory disease treatments | Commercial Services |
Goizueta Business School-Emory
 Goizueta Business School-Emory Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCLA Anderson School of Management
 UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CytomX Therapeutics, Inc.
 CytomX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer | Health Technology |
Unity Biotechnology, Inc.
 Unity Biotechnology, Inc. BiotechnologyHealth Technology Engages in the research and development of therapeutics to extend the human healthspan | Health Technology |
Arcus Biosciences, Inc.
 Arcus Biosciences, Inc. BiotechnologyHealth Technology Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | Health Technology |
Choisissez Zonebourse 
